文献速递神经肿瘤

完全内镜下经蝶手术治疗无功能垂体腺瘤后垂体腺功能恢复:前瞻性多中心研究结果

Pituitary gland recovery following fully endoscopic transsphenoidal surgery for nonfunctioning pituitary adenoma: results of a prospective multicenter study.
PubMed 文献 · J Neurosurg · 2019-11-15

这项美国6个垂体中心的前瞻性多中心研究纳入177例无功能垂体大腺瘤患者,评估完全内镜下经鼻垂体手术6个月后垂体功能恢复情况。169例可随访患者中,95例(56.2%)术前至少一个激素轴缺乏,其中20/95(21.1%)在6个月随访时至少一个轴恢复;肾上腺功能不全者恢复比例(10/34,29.4%)高于甲状腺功能减退者(8/72,11.1%)或男性性腺功能减退者(5/50,10.0%)。术后6个月14/145(9.7%)患者出现至少一个新发缺乏,永久性尿崩症4/166(2.4%)。

要点

  • 术前至少一个激素轴缺乏者中,6个月随访时21.1%(20/95)至少一个轴恢复。
  • 肾上腺功能不全恢复比例29.4%(10/34),高于甲状腺功能减退11.1%(8/72)和男性性腺功能减退10.0%(5/50)。
  • 术后6个月新发至少一个缺乏者9.7%(14/145),永久性尿崩症2.4%(4/166)。

核心结论

  • 完全内镜下垂体手术使相当一部分(但非多数)患者垂体功能改善,最易恢复的是肾上腺功能不全,术后永久性尿崩症总体发生率低,该研究为内镜技术提供了多中心神经内分泌临床结局基准数据。

研究设计与样本

  • 前瞻性多中心研究,在美国6个垂体中心开展,纳入接受完全内镜下经鼻垂体手术的无功能垂体大腺瘤成人患者,共177例入组,169例(95.5%)可随访,术后6个月评估垂体功能。

主要发现

  • 169例可随访患者中,95例(56.2%)术前至少一个激素轴缺乏,20/95(21.1%)在6个月随访时至少一个轴恢复。
  • 肾上腺功能不全者恢复10/34(29.4%),高于甲状腺功能减退者8/72(11.1%)和男性性腺功能减退者5/50(10.0%)。
  • 6个月随访时14/145(9.7%)患者出现至少一个新发缺乏,永久性尿崩症4/166(2.4%)。
  • 研究未发现垂体功能恢复的预测因素(p ≥ 0.20)。
  • 新发垂体功能障碍的预测因素包括较大肿瘤体积(p = 0.009)和Knosp分级3级与4级(p = 0.051)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recovery from preexisting hypopituitarism after transsphenoidal surgery for pituitary adenoma is an important outcome to investigate. Furthermore, pituitary function has not been thoroughly evaluated after fully endoscopic surgery, and benchmark outcomes have not been clearly established. Here, the authors characterize pituitary gland outcomes with a focus on gland recovery following endoscopic transsphenoidal removal of clinically nonfunctioning adenomas. METHODS: This multicenter prospective study was conducted at 6 US pituitary centers among adult patients with nonfunctioning pituitary macroadenomas who had undergone endoscopic endonasal pituitary surgery. Pituitary gland function was evaluated 6 months after surgery. RESULTS: The 177 enrolled patients underwent fully endoscopic transsphenoidal surgery; 169 (95.5%) of them were available for follow-up. Ninety-five (56.2%) of the 169 patients had had a preoperative deficiency in at least one hormone axis, and 20/95 (21.1%) experienced recovery in at least one axis at the 6-month follow-up. Patients with adrenal insufficiency were more likely to recover (10/34 [29.4%]) than were those with hypothyroidism (8/72 [11.1%]) or male hypogonadism (5/50 [10.0%]). At the 6-month follow-up, 14/145 (9.7%) patients had developed at least one new deficiency. The study did not identify any predictors of gland recovery (p ≥ 0.20). Permanent diabetes insipidus was observed in 4/166 (2.4%) patients. Predictors of new gland dysfunction included a larger tumor size (p = 0.009) and Knosp grade 3 and 4 (p = 0.051). CONCLUSIONS: Fully endoscopic pituitary surgery resulted in improvement of pituitary gland function in a substantial minority of patients. The deficiency from which patients were most likely to recover was adrenal insufficiency. Overall rates of postoperative permanent diabetes insipidus were low. This study provides multicenter benchmark neuroendocrine clinical outcome data for the endoscopic technique.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Little AS, Gardner PA, Fernandez-Miranda JC, et al. Pituitary gland recovery following fully endoscopic transsphenoidal surgery for nonfunctioning pituitary adenoma: results of a prospective multicenter study. J Neurosurg. 2019. PMID: 31731279. doi:10.3171/2019.8.JNS191012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。